Long-term outcomes of penile prostheses for the treatment of erectile dysfunction

Expert Rev Med Devices. 2013 May;10(3):353-66. doi: 10.1586/erd.12.92.


Since their introduction 60 years ago, penile prostheses have remained the standard therapy for the management of refractory erectile dysfunction, with multiple long-term series reporting outcomes. A PubMed search was performed from 1990 to present, and outcomes of penile prosthetics were reviewed. Studies with <12 months follow-up were excluded. Overall mechanical survival of three-piece prostheses range from 81-94, 68-89 and 57-76% at 5, 10 and 15 years, respectively. Contemporary infection rates following recent device modifications are 1-2% (low risk) to 2-3% (high risk). Patient satisfaction ranges from 75-100% and varies by prosthetic device. Outcomes are further reviewed among specialized populations (revision surgery, Peyronie's disease, priapism, corporal fibrosis and neurologic impairments). Penile prostheses remain a viable surgical treatment option with excellent mechanical reliability, low infection rates and significant patient/partner satisfaction.

Publication types

  • Historical Article
  • Review

MeSH terms

  • Animals
  • Erectile Dysfunction / therapy*
  • History, 20th Century
  • Humans
  • Male
  • Penile Prosthesis* / history
  • Time Factors
  • Treatment Outcome